Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nicole Watts
Observed name:
Nicole L. Watts
Institutions:
University of Alabama at Birmingham Hospital,
University of Alabama at Birmingham
Observed institutions:
University of Alabama at Birmingham Hospital,
University of Virginia Health System,
University of Alabama at Birmingham,
University of Virginia
ORCID:
0000-0001-9007-9549
Observed ORCID:
0000-0001-9007-9549
OpenAlex ID:
A5072909957
Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN Trials
2022
·
Saurabh Chhabra
, Natalie Callander
, et al.
·
Transplantation and Cellular Therapy
·
74
PDF
Reversible Posterior Leukoencephalopathy Syndrome During Regorafenib Treatment: A Case Report and Literature Review of Reversible Posterior Leukoencephalopathy Syndrome Associated With Multikinase Inhibitors
2014
·
Zaw W. Myint
, Jeremy M. Sen
, et al.
·
Clinical Colorectal Cancer
·
31
Risk of Cytomegalovirus Infection with Post-Transplantation Cyclophosphamide in Haploidentical and HLA-Matched Unrelated Donor Transplantation
2022
·
Omer Jamy
, Courtney Hebert
, et al.
·
Transplantation and Cellular Therapy
·
22
PDF
Mobilization of Hematopoietic Progenitor Cells for Autologous Transplantation Using Pegfilgrastim and Plerixafor: Efficacy and Cost Implications
2018
·
Nicole L. Watts
, Marisa B. Marques
, et al.
·
Transplantation and Cellular Therapy
·
19
PDF
Stem Cell Mobilization Characteristics for Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma (NDMM) Treated with Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab (KRd-Dara)
2022
·
Manisha Bhutani
, Myra Robinson
, et al.
·
Blood
·
4
High Dose Fractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone (mHyperCVAD) Is an Active Regimen in Heavily Pretreated Relapsed/Refractory Multiple Myeloma, Enabling Access to Experimental Therapies
2021
·
Nicole Watts
, Smith Giri
, et al.
·
Blood
·
4
Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide
2017
·
Courtney Hebert
, Nicole Watts
, et al.
·
Transplantation and Cellular Therapy
·
2
Outcomes of Hematopoietic Progenitor Cells Mobilization and Collection Following Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone Induction in Newly Diagnosed Multiple Myeloma
2021
·
Saurabh Chhabra
, Nicole Watts
, et al.
·
Transplantation and Cellular Therapy
·
1
Conventional Versus Low Dose Rituximab in the Treatment of Steroid-Refractory Chronic Graft Versus Host Disease
2018
·
Claire W. Rummage
, Nicole Watts
, et al.
·
Transplantation and Cellular Therapy
·
1
Autologous Hematopoietic Progenitor Cells Mobilization with Combination of Pegfilgrastim and Plerixafor: Efficacy and Cost Assessment
2017
·
Luciano J. Costa
, Racquel Innis-Shelton
, et al.
·
Blood
·
1
The Role of Antibacterial Prophylaxis in Preventing Central Line-Associated Blood Stream Infections (CLABSIs) in Multiple Myeloma Patients Undergoing an Autologous Stem Cell Transplant
2017
·
Nicole Watts
, Aravind Chodavarapu
, et al.
·
Transplantation and Cellular Therapy
·
1
Using A3 Methodology to Identify the Root Cause of a Chemotherapy Error in a Hematopoietic Stem Cell Transplant Patient
2015
·
Kathlene DeGregory
, Leslie Ward
, et al.
·
Transplantation and Cellular Therapy
·
1
Prevalence and Impact of Potentially Inappropriate Medication Use on Post-Transplant Outcomes Among Older Adults with Plasma Cell Dyscrasias Receiving an Autologous Stem Cell Transplant
2022
·
Nicole Watts
, Courtney Hebert
, et al.
·
Blood
Tacrolimus Medication Level Variability Index and Acute Graft Versus Host Disease
2021
·
Riya Patel
, Nicole Watts
, et al.
·
Transplantation and Cellular Therapy
Show more works
View as search
Works count:
14
Citation count:
161
H-index:
4
I10-index:
4
Year
Topic
Type